Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.1 to v3.4.2, which seems to be a minor metadata update with no substantive changes to study design, criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page lists an administrative revision update from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or user interactions are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T14:17:58.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Show glossary was added; the page now includes 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' in the footer. The previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-29T06:20:10.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 'Last Update Posted' timestamp and removes the 'Last Update Posted (Estimated)' timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-22T04:38:44.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The only visible change is the page’s revision tag updating from v3.3.3 to v3.3.4. There is no change to the study content, eligibility criteria, locations, or primary outcomes.
    Difference
    0.1%
    Check dated 2026-01-15T02:02:02.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Introduces a consolidated 'Locations' section with New Jersey and New York sites and updates to Revision: v3.3.3, while removing the separate 'New Jersey Locations' and 'New York Locations' entries.
    Difference
    0.3%
    Check dated 2025-12-23T10:34:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.